Light Sciences Oncology, Inc.

Tokyo-based Solasia Pharma KK said the deal with Meiji Seika Pharma Co. Ltd. covers the development and commercialization in Japan of an intravenous formulation of darinaparsin, which Solasia

Light Sciences Oncology (US) has elected Dr Frank Young to a newly created seat on its board of directors. He held positions in clinical practice, academia and government, including Commissioner of

Despite a miserable economy, new company formation continues apace. In biotech, recapitalizations and structured deals featured prominently; in diagnostics, interest remains strong even if rounds in 2

Biopharmaceutical, medical device, and in vitro diagnostics start-up dealmaking from July through September 2008. Data from FDC-Windhover's Strategic Transactions. Amanda Micklus Financings Financing